Show simple item record

dc.contributor.authorDamment, S
dc.contributor.authorFranklin, R
dc.contributor.authorErusalimsky, Jorge
dc.date.accessioned2018-07-05T12:33:26Z
dc.date.available2018-07-05T12:33:26Z
dc.date.issued2016-06-30
dc.identifier.citationDamment, S., Franklin, R. Erusalimsky, J.D. (2016) PREVENTION AND TREATMENT OF METASTATIC DISEASE IN THROMBOCYTOTIC CANCER PATIENTS, (WO2016102952)en_US
dc.identifier.otherWO2016102952
dc.identifier.urihttp://hdl.handle.net/10369/9674
dc.description.abstractThe present invention relates to the use of the anti-megakaryocytic agent anagrelide or a therapeutically active metabolite therof, in the prevention and/or treatment of metastatic disease in cancer patients displaying paraneoplastic thrombocytosis.en_US
dc.language.isoenen_US
dc.relation.ispartofseriesPatent;WO2016102952
dc.titlePREVENTION AND TREATMENT OF METASTATIC DISEASE IN THROMBOCYTOTIC CANCER PATIENTSen_US
dc.typeOtheren_US
dcterms.dateAccepted2015-12-22
rioxxterms.versionNAen_US
rioxxterms.licenseref.startdate2016


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record